Webinar: Transforming the Treatment Paradigm with Dyne Therapeutics (March 31, 2021)
by: Parent Project Muscular Dystrophy
Dyne Therapeutics joined PPMD for a webinar on March 31, 2021 to provide an overview of the company mission, its novel FORCE platform designed to revolutionize drug delivery to muscle and the company’s Duchenne muscular dystrophy drug development program.